NIH Webinar Series: Moving from Hepatitis Discovery to Elimination

NIH is committed to advancing progress toward viral hepatitis elimination. NIH funded research is focusing on understanding the molecular processes of viral hepatitis infection and the development of new vaccines, diagnostics, and treatment strategies to prevent hepatitis infection and related disease.  Additionally, the NIH released The Strategic Plan for Trans-NIH Research to Cure Hepatitis B for Development of Improved HBV Therapies in 2019  and supports the Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021-2025.   

DCB contributes to these NIH efforts by funding basic research to improve the understanding of the role of viral hepatitis in the development of cancer. 

To facilitate discussions around research and implementation strategies to advance the goal of hepatitis elimination, NIH staff (including Program Directors in DCB) and the Coalition for Global Hepatitis Elimination launched a webinar series, "Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination." The presentations aim to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs.